🎉 M&A multiples are live!
Check it out!

AB Science Valuation Multiples

Discover revenue and EBITDA valuation multiples for AB Science and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

AB Science Overview

About AB Science

AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.


Founded

2001

HQ

France
Employees

103

Website

ab-science.com

Financials

LTM Revenue $1.2M

LTM EBITDA -$23.4M

EV

$102M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

AB Science Financials

AB Science has a last 12-month revenue of $1.2M and a last 12-month EBITDA of -$23.4M.

In the most recent fiscal year, AB Science achieved revenue of $1.0M and an EBITDA of -$5.6M.

AB Science expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See AB Science valuation multiples based on analyst estimates

AB Science P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.0M $1.2M XXX XXX XXX
Gross Profit $1.6M $1.0M XXX XXX XXX
Gross Margin 154% 84% XXX XXX XXX
EBITDA -$5.6M -$23.3M XXX XXX XXX
EBITDA Margin -541% -1975% XXX XXX XXX
Net Profit -$15.2M -$14.6M XXX XXX XXX
Net Margin -1463% -1238% XXX XXX XXX
Net Debt n/a $16.8M XXX XXX XXX

Financial data powered by Morningstar, Inc.

AB Science Stock Performance

As of April 15, 2025, AB Science's stock price is EUR 1 (or $1).

AB Science has current market cap of EUR 85.5M (or $91.9M), and EV of EUR 95.4M (or $102M).

See AB Science trading valuation data

AB Science Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$102M $91.9M XXX XXX XXX XXX $-0.43

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

AB Science Valuation Multiples

As of April 15, 2025, AB Science has market cap of $91.9M and EV of $102M.

AB Science's trades at 84.1x LTM EV/Revenue multiple, and -4.4x LTM EBITDA.

Analysts estimate AB Science's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for AB Science and 10K+ public comps

AB Science Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $102M XXX XXX XXX
EV/Revenue 86.7x XXX XXX XXX
EV/EBITDA -4.4x XXX XXX XXX
P/E -3.9x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get AB Science Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

AB Science Valuation Multiples

AB Science's NTM/LTM revenue growth is 10%

AB Science's revenue per employee for the last fiscal year averaged $10K, while opex per employee averaged $0.1M for the same period.

Over next 12 months, AB Science's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate AB Science's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for AB Science and other 10K+ public comps

AB Science Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 13% XXX XXX XXX XXX
EBITDA Margin -1975% XXX XXX XXX XXX
EBITDA Growth 314% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -1964% XXX XXX XXX XXX
Revenue per Employee $10K XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 37% XXX XXX XXX XXX
G&A Expenses to Revenue 153% XXX XXX XXX XXX
R&D Expenses to Revenue 1080% XXX XXX XXX XXX
Opex to Revenue 1445% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

AB Science Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

AB Science M&A and Investment Activity

AB Science acquired  XXX companies to date.

Last acquisition by AB Science was  XXXXXXXX, XXXXX XXXXX XXXXXX . AB Science acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by AB Science

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About AB Science

When was AB Science founded? AB Science was founded in 2001.
Where is AB Science headquartered? AB Science is headquartered in France.
How many employees does AB Science have? As of today, AB Science has 103 employees.
Who is the CEO of AB Science? AB Science's CEO is Mr. Alain Moussy.
Is AB Science publicy listed? Yes, AB Science is a public company listed on PAR.
What is the stock symbol of AB Science? AB Science trades under AB ticker.
When did AB Science go public? AB Science went public in 2010.
Who are competitors of AB Science? Similar companies to AB Science include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of AB Science? AB Science's current market cap is $91.9M
What is the current revenue of AB Science? AB Science's last 12-month revenue is $1.2M.
What is the current EBITDA of AB Science? AB Science's last 12-month EBITDA is -$23.4M.
What is the current EV/Revenue multiple of AB Science? Current revenue multiple of AB Science is 84.1x.
What is the current EV/EBITDA multiple of AB Science? Current EBITDA multiple of AB Science is -4.4x.
What is the current revenue growth of AB Science? AB Science revenue growth between 2023 and 2024 was 13%.
Is AB Science profitable? Yes, AB Science is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.